Lead: On 24 January 2026 the World Health Organization published a formal response to the United States’ notification to withdraw from WHO, calling the decision detrimental to both U.S. and global health security. WHO said the matter will be examined by the WHO Executive Board at its regular session beginning 2 February 2026 and by the World Health Assembly in May 2026. The statement addressed U.S. criticisms of WHO’s handling of the COVID-19 pandemic and restated WHO’s account of its early actions and continuous support to Member States. WHO also highlighted ongoing multilateral work, including last year’s adoption of the WHO Pandemic Agreement and current negotiations on pathogen access and benefit sharing.
Key Takeaways
- The United States, a founding WHO member, formally notified WHO of its intention to withdraw; WHO described the move as making the United States and the world less safe.
- WHO noted that the Executive Board will consider the notification beginning 2 February 2026 and the World Health Assembly will address it at its May 2026 session.
- The U.S. cited perceived WHO failures during COVID-19, including alleged delays or concealment of information; WHO rejected those characterizations and defended its pandemic response.
- WHO says it activated its emergency incident management system immediately after first reports on 31 December 2019, alerted the world by 11 January 2020 when the first death in China was reported, and declared a PHEIC on 30 January 2020.
- The statement reiterated that WHO advised on masks, vaccines and physical distancing but did not issue universal mandates; responsibility for national policies remained with sovereign governments.
- WHO pointed to recent multilateral progress: adoption in 2025 of the WHO Pandemic Agreement and ongoing talks on the Pathogen Access and Benefit Sharing system to improve detection and equitable access to countermeasures.
- WHO expressed hope the United States will return to active participation while it continues to work with all Member States on global health priorities.
Background
The United States has been one of WHO’s most prominent founding members since WHO’s creation in 1948 and has played major roles in campaigns such as smallpox eradication and sustained efforts against polio, HIV, Ebola, influenza, tuberculosis, malaria and neglected tropical diseases. Over decades U.S. funding, technical expertise and bilateral programs have shaped global health initiatives administered or coordinated by WHO. That long-standing relationship has, at times, been punctuated by political disputes over governance, financing and policy that surfaced prominently during and after the COVID-19 pandemic.
WHO operates as a specialized United Nations agency governed by its 194 Member States under the International Health Regulations. Its formal powers and normative guidance are shaped by Member State mandates, and many recommendations are implemented by national authorities according to local legal and political contexts. The pandemic exposed tensions about WHO’s role, transparency, and how early intelligence and communications were interpreted by different governments and publics.
Main Event
WHO’s 24 January 2026 statement said the U.S. notification of withdrawal is regrettable and described the action as decreasing global safety. The statement summarized WHO’s view that it engaged with the United States in good faith and with respect for U.S. sovereignty, and rebutted specific claims that WHO had ‘‘trashed and tarnished’’ U.S. interests or ‘‘concealed’’ failures during COVID-19.
Addressing the timeline of the early COVID-19 response, WHO noted it asked China for more information after reports of a cluster of unexplained pneumonia cases on 31 December 2019, activated its emergency incident management system, and by 11 January 2020 had publicized alerts and guidance. WHO emphasized that when the Director‑General declared COVID-19 a public health emergency of international concern on 30 January 2020, there were fewer than 100 reported cases outside China and no reported deaths outside China.
In its statement WHO stressed it issued recommendations based on available evidence—urging measures such as mask use, vaccination and physical distancing—but maintained that mandates and national restrictions were decisions for sovereign governments. WHO also pointed to reforms and system strengthening measures taken after multiple pandemic reviews to improve preparedness and response.
Analysis & Implications
Operationally, U.S. withdrawal could reduce predictable funding streams and technical inputs that have supported WHO programs and country-level activities; the United States has historically been one of WHO’s largest contributors through assessed and voluntary contributions. A sudden gap in financing and expertise may force WHO and partner countries to reallocate scarce resources or scale back programs, with potential downstream effects on vaccine distribution, outbreak response and routine health services.
Politically, the withdrawal signals a strain in multilateral cooperation that could encourage other states to question their commitments or negotiate different terms for engagement. WHO’s ability to convene member states and to act as a neutral arbiter in health emergencies depends on broad participation; a high-profile departure risks undermining perceptions of universality that underpin WHO’s legitimacy.
On research and pandemic preparedness, the Pathogen Access and Benefit Sharing negotiations are intended to improve rapid detection and equitable access to countermeasures. If the United States reduces co‑operation on sharing pathogen data or technical platforms, those mechanisms could face practical or political obstacles, affecting global readiness for future threats.
However, the immediate legal and administrative consequences depend on treaty and domestic processes. WHO noted the notification will be handled within its established governance channels; practical outcomes will hinge on the Executive Board and World Health Assembly decisions and on any subsequent U.S. domestic steps to alter funding or participation.
Comparison & Data
| Date | Event |
|---|---|
| 31 December 2019 | WHO received first reports of a cluster of pneumonia cases in Wuhan and requested more information from China |
| 11 January 2020 | First reported death in China; WHO had already issued public alerts and guidance |
| 30 January 2020 | WHO Director‑General declared a PHEIC with fewer than 100 reported cases outside China |
| 24 January 2026 | WHO published its response to the U.S. notification of withdrawal |
| 2 February 2026 | WHO Executive Board begins consideration of the notification |
| May 2026 | World Health Assembly scheduled to address the notification |
The table above collates key dates referenced by WHO in its response and places the notification in the context of the pandemic timeline and upcoming governance milestones. While chronological facts are stated, the table does not presuppose legal outcomes or funding changes, which require separate confirmation.
Reactions & Quotes
WHO framed its position as a defense of its record and a call for continued multilateral engagement in public health. The organization reiterated that it has sought constructive relations with the United States throughout.
“The decision makes both the United States and the world less safe.”
World Health Organization
WHO used this language to summarize its core objection to the withdrawal notification and to underscore its argument that diminished cooperation will raise global risks.
The U.S. government, according to WHO’s statement, accused the agency of failures in the pandemic response, saying it had been “trashed and tarnished” and had compromised independence; WHO rejected those characterizations and set out its chronology and rationale.
“WHO has always sought to engage with the United States in good faith, with full respect for its sovereignty.”
World Health Organization
WHO highlighted this point to stress impartiality and to remind Member States that WHO operates under the mandate of all 194 members.
Unconfirmed
- Whether the U.S. withdrawal notification has completed all domestic legal steps that would finalize an effective exit date remains unspecified in WHO’s statement.
- The immediate fiscal impact on WHO’s 2026 operating budget and specific program funding levels has not been detailed publicly.
- Any bilateral or multilateral arrangements the United States may pursue to maintain specific public health collaborations outside WHO are not described in the statement.
Bottom Line
The WHO statement of 24 January 2026 formally refutes key U.S. criticisms of its COVID-19 conduct, recounts the agency’s early pandemic actions and expresses regret at the U.S. decision to notify withdrawal. The notification will be formally reviewed by the WHO Executive Board beginning 2 February 2026 and then by the World Health Assembly in May 2026, where Member States will have the opportunity to discuss consequences and possible remedial steps.
Observers should watch three near-term developments closely: the Executive Board deliberations in February, policy or funding actions taken by the United States domestically, and any operational adjustments WHO makes to sustain programs in the likely event of reduced U.S. engagement. The broader question is whether this rupture will be temporary and reversible or whether it signals a longer-term shift in U.S. participation in multilateral health governance.
Sources
- WHO statement on notification of withdrawal of the United States — Official WHO press release (official).